Table 1.
Biomaterial inks used in DLP/SLA bioprinting.
| Material | Method | Wavelength | Photo-initiator | Cell | Application | Reference |
|---|---|---|---|---|---|---|
| PEGDA | DLP | Visible light | LAP | hASCs | Tissue modeling | [92] |
| DLP | 365 nm | LAP | HUVECs | Tissue modeling | [93] | |
| PVA-MA+GelMA | DLP | 450nm | Ru/SPS | hMSCs ACPCs | New bioink | [37] |
| GelMA | DLP | 500–550nm | Eosin Y, TEA, NVP | NIH/3T3 | Microscale cell patterning | [49] |
| DLP | Blue light | LAP | hHSCs | Hepatic tissue modeling | [94] | |
| GelMA+PEGDA | DLP | 405 nm | LAP | hMSCs | Vascular modeling | [26] |
| DLP | 405 nm | Eosin Y, TEA, NVP | NIH/3T3 | Microscale cell patterning | [82] | |
| GelAGE | DLP | Visible light | Ru/SPS | HACs | Tissue modeling | [50] |
| HAMA+GelMA | DLP | 365 nm | LAP | hiPSC-HPCs | Hepatic tissue modeling | [71] |
| DLP | 365 nm | LAP | HUVECs | Vascular modeling | [53] | |
| PDLLA-PEG/HA | DLP | Visible light | LAP | hASCs | Cartilage tissue modeling | [95] |
| Sil-MA | DLP | 365 nm | LAP | Human chondrocyte | Cartilage tissue modeling | [55] |
ACPCs: adult cardiac progenitor cells; GelMA: gelatin methacryloyl; GelAGE: allylated gelatin; HAMA: methacrylated hyaluronic acid; LAP: lithium phenyl-2,4,6-trimethylbenzoylphosphinate; NVP: 1-vinyl-2 pyrrolidinone; HACs: human articular chondrocytes; hASCs: human adipose derived stem cells; hHSCs: human hematopoietic stem cells; hiPSC-HPCs: hiPSC-derived hepatic progenitor cells; hMSCs: human mesenchymal stem cells; HUVECs: human umbilical vein endothelial cells; PEGDA: poly(ethylene glycol) diacrylate; PDLLA-PEG/HA: poly(D,L-lactic acid)/poly(ethylene glycol)/hyaluronic acid; PVA: poly(vinyl alcohol); Ru/SPS: tris(2,2’-bipyridyl)dichloro-ruthenium(II) hexahydrate/sodium persulfate; Sil-MA: methacrylated silk; TEA: triethanolamine.